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T lymphocytes proliferate if challenged with a mAb to the CD3 portion ofthe
TCR complex andwith an additional stimulus that is usuallyprovided by phorbol
esters or by accessory cells (1-3). In the latter instance, proliferation requires an in-
tact anti-CD3 antibody(4) as well as Fc receptors (FcR) onthe accessory cells (5-7).
The presentation of anti-CD3 mAb by FcR on accessory cells is thought to mimic
presentation ofantigens on MHC molecules to theclonally specific, a/0heterodimer
ofthe TCR complex. There is little information on the number ofanti-CD3 mAb
onthe accessorycellthat is necessary to induce growth. For the presentation ofspecific
antigens, it likewise is not clearhow many MHC molecules can be associated with
any one type ofpeptide fragment to which individual T cell clones are specifically
precommitted (8-10).
We provide some information on this matter in the studies we describe here on
the anti-CD3 response with epidermal Langerhans cells (LC)t as the accessory cell.
Even though LC express FcR (11-14), we could not predict whether LC would act
as accessory cells since these receptors become undetectable after a day ofculture
(14, 15). Concomitant with this decrease in FcR, there is a 10-30-fold increase in
sensitizing function forT cell proliferative responses to a variety of stimuli (15-17).
We wondered ifboth freshly isolated and cultured LC would be weak accessory cells
for anti-CD3 responses. Fresh FcR+ LC would lack needed sensitizing functions,
and cultured FcR- LC would lack the FcR needed to present anti-CD3 to the T
cell.
Surprisingly, cultured LC proved to be unusually active. This finding was ana-
lyzed quantitatively bydeterminingthenumberoflymphocytesthat were synthesizing
DNA while in contact with individual LC, and by measuring the number ofrequi-
siteFcRmolecules on the LC surface. ThedataindicatethatTcell growth wasbeing
induced byavery small numberofanti-CD3 on the LC surface, -200-300 molecules.
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Materials and Methods
Mice.
￿
H-2d [BALB/c x DBA/2]F, [CxD2], H-2b [C57BL/6] [B6], H-2b x d [B6 x
DBA/2]F, [B6xD2] mice were obtained from the Trudeau Institute (Saranac Lake, NY) and
H-2k CBA/J from TheJackson Laboratories (Bar Harbor, ME). Mice of all strains and of
both sexes, 6-12 wk old, gave similar results.
Epidermal LC.
￿
Single cell suspensions were prepared by trypsinization of mouse ear
epidermal sheets (15, 16). The LC were enriched either immediately(fresh LC)or after2-3 d
in culture (cultured LC). 15-20 x 106 epidermal cellswere cultured per 100-mm tissue cul-
ture dish (No. 3003, Falcon Labware, Oxnard, CA)in RPMI 1640 (Gibco Laboratories, Grand
Island, NY) supplemented with 5% FCS (Hazelton Systems, Inc., Aberdeen, MD), 5 x 10-5
M 2-ME (Sigma Chemical Co., St. Louis, MO)and20 l~g/ml gentamicin (Gibco Laborato-
ries). Fresh and cultured LC were enriched from the suspension as described (16). Briefly,
epidermalcellswere treated with mAb antiThy-1 plus complement to kill most keratinocytes,
followed by 0.1% trypsin-160 ttg/ml DNase to remove dead cells. Aftercoding with rat mAb
to the mouse common leukocyte antigen (CD45; clone M1/9, TIB122 from the American
Type CultureCollection [ATCC], Rockville, MD), thecellswere panned on petridishes coated
with goat-anti-rat Ig. The nonattached cells were washed off, and the adherent LC were
eluted by pipettingin the presence of ratIg.Thepopulations thus obtained consisted of 65-90%
fresh LC and 90-98% cultured LC as determined by immunofluorescence with FITC-
conjugated mAb anti-I-Ab,a (B21-2, TIB229 from ATCC) and by phase-contrast microscopy
in the case ofcultured LC . Previously it wasshownthat the panningmethod did notsignificantly
alter the accessory function of LC during MLR stimulation (16). To show that coatingwith
mAb did not affect function in anti-CD3 responses, the final panning step was omitted in
some experiments; the resulting fresh and cultured LC were only 6-12% and 30-50% LC
but the accessory function per LC was similar (data not shown). In addition, cultured LC
were also enriched by flotation on bovine plasma albumin columns (15). This was the most
convenient method, providingpopulations that were 30-60% LC and that functioned com-
parably to panned, highly enriched LC.
OtherAccessory Cells.
￿
Peritoneal washoutcellswere used as the source ofmacrophages(N30 %
macrophages) in most experiments. Dendritic cells were prepared from thelowdensity, ad-
herent cell fraction of collagenase-digested spleens and thymi. After overnight culture, the
cellsthat had eluted from the culture dish were depleted ofmacrophages and B cellsby roset-
ting with EA to provide an EA- dendritic cell fraction (18, 19). Spleen and thymus macro-
phages were the cells that remained adherent after overnight culture. They were released
from the dishes by treatmentwith 5 mM EDTA in PBS for 30 min at 37°C. B cells included
the A20 B lymphoma cell line (TIB208, ATCC), as well as LPS-induced B lymphoblasts
that were prepared from spleen.
Responder T Cells.
￿
Spleen and/or mesenteric lymph nodes were passed over nylon wool
columns and the nonadherent cells treated with anti-Ia mAb (B21-2, TIB229 and M5/114,
TIB120 for H-2d,b, andbxd strains; 10.216, TIB93 for H-2k strains) plus complement. Where
indicated, CD4' and CD8' T cell subsets were enriched by adding mAb anti-Lyt-2 (CD8,
3.155, TIB211) or GK 1.5 (CD4, TIB207) during the complement treatment above. Purity
ofthe subsets wasverified to be >95% by flow cytometry with FITC-anti-CD8 (clone 53-6.72)
and PE-anti-CD4 (clone GK 1.5) purchased from Becton Dickinson &Co. (Mountain View,
CA). Except when we used lymph node as the source of T cells, the populations were en-
riched by an additional step involving sedimentation in discontinuous Percoll gradients
(45-54-63% Percoll) in which dead cells and remaining accessory cells floated.
Proliferation Assays.
￿
Graded doses of accessory cells (irradiated with 1,000 rad "'Cs; A20
cells received 9,000 rad) were added to 2-3 x 105 syngeneic T cells in flat-bottomed, 96-
well plates (No. 25860; Corning GlassWorks, Corning, NY). mAb 2C11, hamster anti-mu-
rine CD3 (20), was a generous gift of Dr. J. Bluestone (University ofChicago, Chicago, IL)
and was added either as ascites (1:2,000 final dilution) or as culture supernatant (100 /0 final
concentration). Cells were cultured in RPMI 1640 with 1-5°Io FCS, gentamicin, and 2-ME.
[3H]Thymidine incorporation was measured at 28-44 h (4 IACi/ml; 6 Ci/mmol). The re-
sponse to ConA (1 kg/ml; Miles Laboratories, Naperville, IL)was measured identically. The
allogeneic MLRwas run in medium containing 5% FCS and was routinelypulsed 72-90 h.ROMANI ET AL.
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To check for blocking activity, mAbs (see Results) were used as culture supernatants (5-25%
vol/vol) except for 2AG2 anti-FcR mAb, which was also used as a purified Ig and Fab frag-
ment (21).
Single Cell Studies to Monitor T Cell Proliferation.
￿
To measure the number ofT lymphoblasts
that were induced by a given number ofadded LC, the size of the T cells stimulated as above
was evaluated at 24-52 h by forward light scatter in a FACScan instrument (Becton Dick-
inson & Co., Mountain View, CA). Before analysis, a viable (trypan blue-negative) cell count
was taken. Then the cells were exposed to 2 kg/ml ethidium bromide, to label and gate out
dead cells, and vigorously resuspended to dissociate clusters of LC and T lymphoblasts. The
latter showed at least twice the forward light scattering of small T cells (see Results). To
enumerate the number of T cells in the S phase of the cell cycle while in contact with LC,
autoradiography and anti-Ia immunolabeling were combined on cytospin samples of the cul-
tures. Two to three cytospins could be prepared from each microtest culture which had been
pulsed at 30-36 h with 4 1Ci/ml [3H]TdR. Most of the medium was replaced with fresh
medium to dilute out unincorporated radiolabel before sedimentation onto glass slides
(Shandon Cytospin 2, Southern Instruments Inc., Pittsburgh, PA). The slides were air dried,
fixed in acetone (5 min, room temperature), and stained for Ia antigens using biotin-anti-mouse
la (2 Wg/ml each ofB21-2 and 14-4-5S, HB32), avidin-biotin-peroxidase complex (Vectastain;
Vector Laboratories, Burlingame, CA), and diaminobenzidine/H202 . After dehydration in
ethanol the air-dried cytospins were dipped in Nuclear Track Emulsion (Eastman Kodak
Co., Rochester, NY) and exposed at 4°C for 36 h. The slides were developed (Kodak D-19),
fixed (Kodak Rapid-Fix), stained with hematoxylin, and mounted in Permount. [3H]TdR-
labeled cells that were clustered with Ia' LC were counted on most microscopic fields at
x 500. >500 T cells on duplicate or triplicate specimens were examined.
Expression of FcR.
￿
For flow cytometry, cell suspensions were double-labeled with mAb,
one of which was an anti-la to identify the la' LC and the other a rat anti-mouse mAb
of the IgG2b isotype (14, 19), including: 2AG2 anti-FcR; Ml/70 anti-C3biR or CD11b; B5-3
antiThy-1; GK1.5 anti-CD4; 33D1 anti-dendritic cell; F441.8 anti-LFA-1 or CD11a; and B21-
2 anti-I-A. These other mAbs served as positive and negative controls, 33D1 and B5-3 being
nonreactive with mouse LC . The cells were incubated in sequence with rat mAb (culture
supernatants), FITC-mouse anti-rat Ig (2 Wg/ml; Boehringer Mannheim Biochemicals, In-
dianapolis, IN), biotin mouse anti-I-E (2 jig/ml; clone 14-4-5S), and PE-streptavidin (B-D) .
The suspensions were fixed in 3 .7% formaldehyde and analyzed on a FACScan (B-D). Dead
cells and debris were gated out as events with a lower forward light scatter than lymphocytes.
For the detection of intracellular FcR, fresh and cultured LC were cytospun onto glass
slides, fixed with acetone (10 min/-20°C), air dried, and incubated with culture superna-
tants ofthe 6B7C rat IgG2a anti-FcR mAb (22), with 53-7.3 and 53-6.7 anti-CD5 and CD8
as nonreactive controls. Alternatively, the panel consisted of rat IgG2b hybridomas: 2AG2
anti-FcR, Ml/70 anti-C3biR, and B21-2 anti-l-A with 33D1 anti-DC as nonreactive control.
The secondary mAb was FITC-mouse anti-rat (as above).
Cell surface FcR were quantitated with 1251-2 .4G2 binding assays done in suspension in
96-well round-bottomed plates (Flow Laboratories, McLean, VA) in a total volume of 100
til. 2 x 105 cells were incubated for 60 min at 4'C on a nutator with the 12'I-2.4G2 at 1'ug/
ml, 2-5 x 106 cpm/Wg, in PBS containing 17o BSA and 0.02% sodium azide. After three
washes the cells were transferred to plastic Eppendorf tubes for gamma scintillation counting.
Specificity was calculated by blocking with a 50-fold excess of cold 2AG2 added before the
radiolabeled mAb for 30 min at 4°C. The binding was saturable as described (21, 23).
Results
Cultured LC Are Potent Accessory Cells in Anti-CD3 Responses.
￿
To study accessory cells
for murine T cell responses to anti-CD3, it was necessary to extend standard methods
for depleting accessory function in T cell preparations. Under our culture condi-
tions, nylon wool-nonadherent, Ia- spleen cells did not proliferate to 1 ug/ml Con
A but did give sizable backgrounds to anti-CD3, up to 20,000 cpm per culture. This1156
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could be reduced to <1,000 cpm by using lymph node rather than spleen cells, or
more conveniently, byadding astep tothespleen Tcellpurificationinvolvingsedimen-
tation indensePercoll (see Materials and Methods). Such T cellsrespondedvigorously
in the MLR and to the lectin Con A (Fig. 1) when low doses of cultured LC, or
spleen or thymic dendritic cells, were added. Freshly isolated LC were much less
active as accessory cells (Fig. 1) as noted previously (15, 16, 24).
When anti-CD3 was themitogen, cultured LC were again muchmore potent than
fresh LC (Fig. 1). This activity was unexpected since anti-CD3 responses require
FcR (4-7), and cultured LC had shown little rosetting of erythrocytes maximally
coated with antibody (EA) nor reactivity with the 2AG2 anti-FcR mAb (14, 15).
Yet the LC were active as FcR-rich peritoneal macrophages [Fig. 1].
When cultured LC were compared with other dendritic cells, EA- thymic den-
dritic cells were asactive, but spleen dendriticcells were weak(Fig. 1). The function
of spleen dendritic cells could be due to small numbers (<5%) of contaminating
EA' macrophages and B cells and was not pursued further. Instead, the potent ac-
cessory function of cultured LC and thymic dendritic cells was evaluated.
Surface Molecules Involved in the Anti-CD3 Response.
￿
2C11 anti-CD3 was the only
anti-T cell reagent that could stimulate proliferation inthe presence ofLC. Inactive
mAbwere: antiThy-1, clones HO-13.4 and B5-3; anti-Lyt-1/CD5, clone 53-7.3; anti-
C134, GK1.5; anti-CD8, clones 53-6.7 and 3.155; antiTCR, cloneKJ16; anti-CD45,
clone M1/9; and F441.8 anti-LFA-1 (not shown).
The 2AG2 mAb tothe murine, trypsin-resistant, immune complexreceptor (FcR
II) inhibited the proliferative response to LC plus anti-CD3 . The inhibition was
>90% irrespective of the form of 2AG2 used: purified Ig (2-10 NAg/ml), Fab frag-
ments (10 Ag/ml), or hybridoma culture supernatant (25% vol/vol) (Fig. 2, top) . In
contrast to anti-CD3 responses, 2AG2 did not block proliferation to the mitogen
Con A(Fig. 2, top) or in the MLR (not shown). We were unable to block the anti-
CD3 response ifeither the LC orthe T cells, or both, were treated with 2AG2 and
washed before coculture (not shown).
The anti-CD3 response was resistant to anti-CD4 and anti-Ia mAb. These mAb
did inhibit the MLR induced by LC, as expected for an antigen-specific response
(Fig. 2, middle). The F441.8 anti-LFA-1 mAb markedly blocked the 2C11 response
(Fig. 2, bottom). Both CD4 and CD8 T cell subsets were stimulated by LC plus anti-
CD3 (Fig. 2, bottom). Isotype-matched control mAb did not block, such as Ml/70
anti-CD 11b; F4/80 anti-macrophage; B5-3 antiThy-1. Nor was blocking observed
with high doses ofmouse myelomas (LPC-1, IgG2a; J606, IgG3) or human Ig that
interact with other FcR (not shown). Therefore proliferative responses to anti-CD3
and cultured LC require FcR II and CD3, but do not seem to require MHC class
I/I1 or CD4/CD8 molecules.
Detection of Small Numbers ofFcR on Cultured LC but not TCells.
￿
We used a FAC-
Scan, a new sensitive cytolluorograph, and two-color immunolabeling to reinves-
tigate the expression of FcR on Ia+ LC with 2AG2 mAb. This rat IgG2b mAb
stainedfresh LC at 10-20 times the background observed with no primary mAb or
isotype-matched nonreactive controls (GK 1.5 anti-CD4; B5-3 antiThy-1; RA3-6A
anti-B220; 33D1 anti-dendritic cell) (Fig. 3 A). After 1-3 d ofculture, the LC still
stained with 2AG2, but the staining was very much weaker than on fresh LC andE
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The function of five different populations, including fresh and cultured LC, during
T cell mitogenesis . Graded doses of fresh and 3-d cultured LC (here labeled EC), spleen and
thymic dendritic cells (Fc receptor weak dendritic cells were isolated from low density adherent
cells, LODAC, by depleting cells that rosetted with antibody-coated erythrocytes EA), and peri-
toneal macrophages were added to 3 x 105T cells in microtest cultures . All accessory cells were
from B6xD2 H-2bxd mice andwere irradiated with 1,000 rad . TheT cells were from the same
mice, except forthe allogeneic MLR, whereCxD2 H-2dT cells were used . Proliferativeresponses
were measured at 72-90 h in the allogeneic and syngeneic MLRs, and at 28-44 h in the Con
A and anti-CD3 responses .
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Blocking of the anti-CD3 response with mAbs. Proliferative responses were gener-
ated with 3 x 105 T cells and 3 x 103 (top) or 103 (middle, bottom) cultured LC. (Top) Blocking
of anti-CD3 but not Con A responses with 2AG2 anti-FcR mAb. Cultures were set up with no
mAb, 10 Wg/ml intact Ig, and 10 /Ag/ml Fab fragment of 2AG2 Ig. (Middle) Anti-la blocks the
MLR induced by LC, but not the anti-CD3 response. The LC were from CBA/J H-2k mice
or from CxD2 H-2d mice. Syngeneic cells were used for the anti-CD3 response, and the reciprocal
allogeneic cells for the MLR. The anti-Iak mAb was 10-2 .16 anti-I-Ak. Hybridoma culture su-
pernatants were used at a dose of 25% vol/vol. (Bottom) Anti-LEA-1 but not other mAb blocks
the anti-CD3 response of both CD4 and CD8 T cell subsets.
about twice background (Fig. 3 B). Reactivity with anti-laincreased fivefold, as de-
scribed (14).
In contrast to LC, T cells gave strong signals with anti-LFA-1 and antiThy-1, but
no staining at all with 2AG2 and anti-Ia (not shown).
We then did two-color FAGS analyses on the mitogenesis cultures, using anti-la
to distinguish the LC from T cells (activated mouse T cells do not express Ia). TU c m
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Anti-CD3 induced mitogenesis cultures (LC and T cells) were also stained at 24 h with the same
system, i.e., PE-anti-Ia to identify LC and a second FITC mAb. Cells from H-2k mice were used so
that the B21-2 anti-I-Ad mAb served as nonreactive isotype-matched rat IgG2b control. The T cells
were separated into small lymphocytes andlargelymphoblasts (see Fig. 6below) on thebasisofforward
light scattering. Shown here is the lack of 2AG2 staining on the T blasts (C) and the LC (D).
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blasts and smallTcells were separated by forward light scattering (see below). Both
T cell populations were Thy-1+, LEA-1+, FcR- (Fig. 3 C). The Ia+ cells had even
less FcR than the LC added to the mitogenesis culture (Fig. 3 D), possibly because
the FcR were occupied by the 2C11 anti-CD3 mAb.
We did additional studies looking for FcR since the above studies would fail to
detect pools ofintracellular and occupied FcR. Cytospun, permeabilized specimens
of the cells were stained with 2AG2 or with a second anti-FcR mAb 6B7C. The
latter IgG2a mAb recognizes a membrane proximal epitope (25) that is found on
all FcR molecules recognized by 2.4G2 but is normally obscured on live cells (22).
The 6B7C epitope however is readily detected in B cells in tissue sections and cell
lysates (22). When either the 6B7C or 2AG2 mAb were used to stain the LC-T cell
cultures, no staining was observed, in contrast to staining with anti-Ia, which was
bright (Fig. 4). Clear cut staining with both anti-FcR mAbswasobserved in perito-
neal macrophageswhen the latter were used as APC fortheanti-CD3 response(Fig.
4) and in A20 B lymphoma cells (not shown).
To quantitate FcR on cultured LC and other FcR+ cells, binding assays were per-
formed with 1251-2.4G2. In all cases, the bindingwas specific since it was abrogated
by a 50-fold excess of cold 2AG2 but not by other Ig. Fresh LC had about 20,000
binding sites/cell, while cultured LC had 2,000 (Table I). Spleen dendritic cells had
about 1,000 binding sites, but it was not determined ifthis was due to a few con-
taminating B cells or macrophages. The latter cells, exemplified by LPS-induced
B blasts and peritoneal macrophages, expressed 20-60,000 bindingsites/cell (Table I).1160
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Two approaches (not shown) verified that the small amounts of 1251-2.4G2 binding
were due to LC, not keratinocytes . By autoradiography, the 2.4G2-labeled cells all
had the cytologic features of LC . Second, we bound 1251-2.4G2 to mixtures of LC
and keratinocytes and then found that the label was carried by cells that could be
panned with anti-Ia mAb (anti-LC) but not with antiThy-1 (anti-keratinocyte) .
We conclude from this group of studies that a very small number ofFcR are ex-
FIGURE 4 .
￿
Failure to identify pools ofintracellularFcR in LC orT cells during anti-CD3 mito-
genesis responses . Mitogenesis was induced usingFcRrich peritoneal macrophages [A-C, F] as
accessory cells or FcR-poor cultured LC [D, E] . At 24 hthe cells were cytospun onto slides, fixed
in acetone, and stained with a panel of mAb followed by FITC-mouse anti-rat Ig. The IgG2b
mAbwere Ml/70anti-C3biR orCD11b [A],2AG2 anti-FcR [B, E], B21-2 anti-I-A [D]and 33D1
anti-DC [the non-reactive control, not shown] . The IgG2a mAb were 6137C anti-FcR [C] and
the isotype-matched control 53-6 .7 anti-CD8 [F; reactive with T cells but not APC] . All micro-
graphs were exposed anddeveloped identically to allow foracomparison of fluorescence intensi-
ties . Phase contrast and fluorescence are shown for representative fields . The arrows mark the
APC . 200x .ROMANI ET AL .
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pressed on cultured LC and that these are essential forpresenting anti-CD3 to FcR
negative T cells.
Comparison of CulturedLC with other FcR-bearingAPC .
￿
Dose-response curves were
obtained tocompare the function ofcultured LC with many othertypes ofaccessory
cell . For each population, we measured theaveragenumber of specific2AG2 binding
sites. In all cases, the cultured LC were as or more active than other, FcR-rich APC.
Cultured LC were more active than fresh LC, as active as peritoneal macrophages
and the A20 lymphoma, and more active than LPS-induced B blasts (Fig . 5) . The
activity of every population was blocked >90% by 2AG2 mAb (Fig . 5, bottom) .
TheFrequencyofTCells that Enter Cell CycleperLC
￿
To detect responding cells that
developed upon coculture with cultured LC plus anti-CD3, themitogenesis cultures
were analyzed for forward light scattering as a measure of cell size. In two experi-
ments after 38 h of coculture with 2 x 103 LC and anti-CD3 mAb, -50% of all
viable cells were blasts (Fig. 6) . This corresponds to 50 blasts per LC in 38 h . Since
T cells could go through two rounds of division in this time, we estimated that at
least 25 blasts are induced by one LC in a day. The response, whether measured
using [3H]TdR uptake or numbers oflymphoblasts, was directly related to the dose
of LC (Fig . 6, bottom).
SinceT cells could be binding to and then disengaging from LC during the anti-
CD3 response, we made cytospin preparations of the [3H]TdRlabeled cultures to
identify thoseTblasts that were in contactwith LC atanyone time . Giemsa staining
roughly distinguished the cell types by their tinctorial properties, and showed large
numbers of lymphoblasts in contact with the LC (Fig. 7, left). If the preparations
were stained with anti-Ia and then processed for autoradiography, T cells that were
in S phase while in contact with Ia+ LC could be counted (Fig . 7, right) . On av-
erage, 7 .5 (two experiments) proliferating cells perLC were found in the clusters,
regardless of the dose of LC used to initiate the response (Fig . 6, legend) .
TABLE I
The Number ofTcR (2.4G2 Binding Sites) per Cell
Cell type Binding sites t SD Number of experiments
Langerhans cells, fresh 19,000 t 11,000 3
Langerhans cells, cultured 2,000 t 1,000 11
Resident peritoneal macrophages 67,000 t 50,000 6
Spleen macrophages 63,000 2
Thymus macrophages 119,000 1
Spleen dendritic cells 1,000 t 300 3
Thymic dendritic cells 10,000 2
Lymph node dendritic cells 2,000 1
Spleen EA' adherent cells 9,000 t 5,000 3
Thymic EA' adherent cells 12,000 2
A20 B cell lymphoma 57,000 t 24,000 6
LPS-induced B blasts 31,000 11162
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FIGURE 5 .
￿
A comparison of several different types of accessory cells for anti-CD3 mitogenesis
responses in which the populations were also monitored for the number of 125I-2 .4G2 binding
sites . All the LC (here labeled epidermal cells) populations were purified by panning. The top
left panel compares fresh and cultured LC in the absence or presence of 2C11 anti-CD3 mAb .
The top right compares cultured LC with the dendritic and macrophage components of spleen
adherent cells, as well as peritoneal cells andtheA20 lymphoma . The latter were tested without
or with prior exposure to the antibody coated erythrocytes (EA) that are used to deplete FcR
bearing cells . The bottom panels are comparable experiments, but 2AG2 anti-FcR mAb was
added to show that the mitogenesis responses require functioning FcR .
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FIGURE 6 . The proliferative re-
sponse to anti-CD3 mAb and
graded doses ofcultured LC : single
cell analyses . Anti-CD3 mitogen-
esis cultures were set up in standard
microtest cultures with 2 x 105 T
cells and graded doses of cultured
LC . At 38 h, theT cell response was
monitored with a numberofdiffer-
ent assays on replicate samples . The
frequency vs . forward light scatter
plots provide a measurement ofcell
size using samples in which dead
cells were gated out by ethidium
bromide staining . Below are the
symbols for the different doses of
LC (') and the yields of blasts ($ ;
the cells in the high forward scatter
peak) . Also shown in the table is the
level ofDNA synthesis after a pulse
with [ 3H]TdR from 31 to 37 h (11)
and the ratio of the total number
of [ 3H]TdR-positive cells to the
number of Ia' LC in discrete LC-
T cell clusters (§ ; see Fig . 7) . NI,
Not included in the figure.
FIGURE 7 .
￿
Cytologic approaches to the proliferative response to anti-CD3 mAb and cultured
LC . Anti-CD3 mitogenesis responses were induced with graded doses ofLC as in Fig. 6 . Ali-
quots ofthe cultures were stained with Giemsa to distinguish enlarged lymphoblasts from small
T cells (left) . A presumptive LC, the cytoplasm ofwhich does not take up the dyes in the Giemsa
stain, is arrowed. To quantitate blastogenesis relative to the number of LC, the cultures were
exposed to [3H]TdR at 30-36 h . The cells were spun onto glass slides, stained with anti-Ia using
an immunoperoxidase method (biotin anti-I-A and anti-I-E plus avidin-biotin-peroxidase com-
plex), and then processed for autoradiography followed by hematoxylin staining (right) . Note the
large numbers ofcells with silver grains in association with the peroxidase labeled LC (arrows). x 240.
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Discussion
Detection ofFcRon Some Types ofDendritic Cells.
￿
One of thecharacteristics features
of most dendritic cells is a lack of FcR. This has been apparent by many criteria:
weak reactivity with anti-FcR mAb (14, 26), little or no binding of immune com-
plexes and antibody-coated particles in vitro and in situ (18, 27), and weak accessory
function for anti-CD3 stimulation of T cells (28). The one exception has been the
epidermal LC, which expresses FcR in situ and immediately upon isolation (11-14)
but loses most of these FcR within a day of culture (15).
We now find that some dendritic cells, particularly those in thymus and in cul-
tured epidermal suspensions, retain small but detectable levels of FcR. These low
levels were detected using binding assays with 1251-2 .4G2 mAb and by flow cytom-
etry using a polyclonal FITC-mouse anti-rat Ig reagent and a sensitive FACScan
instrument (Table I, Fig. 3). In the accompanying paper, we will show that freshly
isolated LC are very active in presenting exogenous protein antigens to chronically
stimulated T cell clones, whilecultured LC are inactive. We suspect that the physio-
logic role of the relatively high levels of FcR on fresh LC may be to help process
immune complexes. The capacity to handle immune complexes, like the capacity
to handle soluble proteins (accompanying paper) may be downregulated as LC ac-
quire the additional functions required to sensitize T cells.
In discussing the findings of this paper, we are assuming that the capacity of LC
to stimulate anti-CD3 responses may not relate directly to the physiologic role of
LC FcRbut insteadprovides a model forthe efficacy of natural ligandsfor theTCR,
i.e., complexes ofantigenand MHC. At present, thereis no way to quantitate specific
MHC-peptide complexes directly, so the anti-CD3 system is essentially a working
model in which one can obtain quantitative information. The model is afascinating
one when the quantitative findings are considered. Since LC only express -2,000
surface FcR, and we are unable to detect a significant intracellular pool, then an
average of200-300 FcR are sufficient to stimulate any of the seven to eight T cells
that a LC is triggering at any one time (Figs. 6, 7).
Possible Roles of the FcR in the Anti-CD3 Response.
￿
Soluble anti-CD3 mAb, in the
absence of accessory cells, does not induce human T cells to enlarge, secrete lym-
phokines, or become responsive to low doses of IL-2 (29). We have confirmed this
in the 2C11 anti-murine CD3 system (Inaba, K., N. Romani, and R. M. Steinman,
submitted for publication). Therefore a limiting feature of the anti-CM response
is the small number of anti-CD3 bound to LC FcR molecules. One hypothesis for
the role of FcR on the accessory cell is to allow aggregation of the anti-CD3 mole-
cules, which then more effectively stimulate the T cell. This hypothesis stems from
the enhanced stimulatory capacity of anti-CD3, forT cell clones, if coupled to solid
supports like Sepharose (30). If FcR are needed to form aggregates of anti-CD3,
it is of interest that these can assemble in spite oftheir low numberson cultured LC.
FcR on the LC also may provide a required stimulus in addition to anti-CD3.
We have not identified FcRmediated second signals as yet. We asked whether the
FcRCD3 interaction might activate thephysiologic system forantigen presentation
in which MHC molecules on the APC and CD4 molecules on the T cell participate.
However, mAb to la and to CD4, which block LC function in the MLR, did not
significantly block the anti-CD3 response (Fig. 2). We have looked for soluble ac-
tivating factors that might emerge from clusters of anti-CD3-stimulated LC andROMANI ET AL.
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Tcellsbuthave foundnone. Specifically, ifin onechamberofa two-chamberculture
system we placeclusters ofLC and responding Tcells, and into the second chamber
place anti-CD3 plus T cells, the latter do not enlarge, become IL-2 responsive, or
synthesize DNA (Inaba, K., et al., submitted for publication).
A third possibility is that FcR do not directly trigger any change in the LC but
simply approximate theanti-CD3 "opsonized" Tcellstothe LC. Then other proper-
ties ofthe LC induce mitogenesis. This too does not seem to be the case. We have
found that cultured LC and T cells cluster with one another to comparable extents
in the presence or absence ofanti-CD3 when the cells are mixed forjust 3 h. These
LC-T cell clusters then proliferate vigorously ifanti-CD3 is added. Therefore anti-
CD3 is not simply an opsonin for LC FcR. Anti-CD3 molecules on LC FcR are
providing a stimulus to the T cell that seems to be independent ofanother mecha-
nism that brings dendritic and T cells together.
TheAccessory Function ofLCDevelops in Culture.
￿
Prior studies have shown that cul-
tured LC are muchmore active accessory cells foravariety ofT-dependent responses
(15, 24, 31), and that this development of accessory function can be mediated by
granulocyte/macrophage CSF(GM-CSF) (16, 17). One difficultyin interpreting these
priorexperiments is that the ligand forthe TCR for antigen wasnot able tobequan-
titated, so that the observed increase in LC accessory function could reflect an in-
crease in ligands forthe TCR. Forexample, in the MLRwe quantitatedMHC prod-
ucts (15, 16), but an MHC product in the absence ofbound peptides (32) may not
berecognized bythe TCR. Inoxidative mitogenesis(15, 17), one also does notknow
the ligand for the TCR.
However, in anti-CD3 responses, the ligand for the TCR complex is anti-CD3,
therebeing no evidence for a role for other moleculeslike CD4 and MHC products
(Fig. 2). What we have found is that LC function during anti-CD3 responses in-
creases markedly in culture even though the level of FcR, the only known ligand
for the TCR/CD3 complex in this model, decreases (Table 1, Fig. 2). This suggests
that someotheraspect ofLC function, otherthan presentationofligand to theTCR,
is developing in culture.
One such function, which as mentioned above is independent ofFcR, is the ca-
pacity to form tight, stable aggregates with T lymphocytes (Inaba, K., et al., sub-
mitted for publication). We find that freshly isolated LC, with sizable numbers of
FcR, can form clusters with Tcells, but that these clusters are small and unstable
eveninthe presence ofanti-CD3 . Theaggregates are easily dissociatedby handling,
anddisassemble spontaneously ifplaced in culture. The stabilityofclusters formed
with LC that have been cultured one day is also very weak relative to those formed
with day 3 cultured LC. Therefore, the capacity ofcultured LC to stimulate aCD3
response may reflect, at least in part, the capacity to retain T cells for prolonged
periods and/or to provide surface-dependent stimulatory signals.
Can a SmallNumber ofAntigen-MHC Complexeson a Dendritic CellInduce TCellMito-
genesis? One ofthe features to emerge from recent studies ofantigen presentation
is that it may be very difficulttooccupy alarge proportion ofan APL'scomplement
ofMHC moleculeswith onetypeofantigenicpeptide. When peptides are generated
by proteolysis, there may be many different peptides to which an APC is exposed
at any one time, including those derived from self proteins in the environment of
the APC.
Antigens likely interact with the a/(3 component ofthe TCR complex and then1166
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the CD3 system is engaged. It is considered that anti-CD3 simply bypasses the signal
delivered by antigen-MHC to the TCR complex (29). To the extent that anti-CD3
engagement of the TCR is analogous to physiologic engagement by antigens, very
small numbers ofantigen-MHC complexes may be effective when presented on den-
dritic cells. This would mean that the function of high levels of MHC molecules
on dendritic cells is to carry different kinds of antigen rather than large amounts
of just one peptide. Given the capacity ofdendritic cells to fully activate at least 25
T cells per day, and 8 T cells at any one time, it is possible that many different lym-
phocyte clones can be selected by individual APC.
Summary
Resting T cells enter cell cycle when challenged with anti-CD3 mAb and acces-
sory cells that bear required Fc receptors (FcR) . Presentation of anti-CD3 is thought
to be a model for antigens presented by accessory cells to the TCR complex. We
have obtained evidence that the number of anti-CD3 molecules that are associated
with the accessory cell can be very small. We first noticed that thymic dendritic cells
and cultured, but not freshly isolated, epidermal Langerhans cells (LC) were active
accessory cells for responses to anti-CD3 mAb. DNA synthesis was abrogated by
a mAb to the FcR but not by mAb to other molecules used in clonally specific anti-
gen recognition, i .e., class I and II MHC products or CD4 and CD8. The requisite
FcR could be identified on the LC but in small numbers. Freshly isolated LC had
20,000 FcR per cell, while the more active cultured LC had only 2,000 sites, using
1251-anti-FcR mAb in quantitative binding studies. Individual LC had similar levels
of FcR, as evidenced with a sensitive FACS. FcR could not be detected on T cells
or within the dendritic cell cytoplasm, at the start of or during the mitogenesis re-
sponse. When the response was assessed at 30 h with single cell assays, at least 20
T cells became lymphoblasts per added LC, and at least 8 T cells were synthesizing
DNA while in contact with the LC in discrete cell clusters. To the extent that anti-
CD3 represents a polyclonal model for antigen presentation to specific T cell clones,
these results suggest two conclusions. First, only 200-300 molecules of ligand on
dendritic cells may be required to trigger a T cell. Second, the maturation of LC
in culture entails "sensitizing" functions other than ligand presentation (anti-CD3
on FcR) to clonotypic T cell receptors.
The authors thank Dr. J . Bluestone for providing the 2C11 anti-CD3 mAb, Dr. A. Granelli-
Piperno for help with autoradiography, and J. Adams for graphics and photography.
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